PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 11 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,375,000 | +11.8% | 2,500,000 | 0.0% | 1.11% | +7.5% |
| Q1 2018 | $2,125,000 | 0.0% | 2,500,000 | 0.0% | 1.03% | -9.6% |
| Q4 2017 | $2,125,000 | 0.0% | 2,500,000 | 0.0% | 1.14% | -13.3% |
| Q3 2017 | $2,125,000 | +9.8% | 2,500,000 | 0.0% | 1.32% | -4.5% |
| Q2 2017 | $1,936,000 | -1.4% | 2,500,000 | 0.0% | 1.38% | -16.8% |
| Q1 2017 | $1,963,000 | +27.0% | 2,500,000 | 0.0% | 1.66% | +22.2% |
| Q4 2016 | $1,546,000 | +1.4% | 2,500,000 | 0.0% | 1.36% | +27.9% |
| Q3 2016 | $1,525,000 | -7.2% | 2,500,000 | 0.0% | 1.06% | -18.5% |
| Q2 2016 | $1,644,000 | 0.0% | 2,500,000 | 0.0% | 1.30% | -8.1% |
| Q1 2016 | $1,644,000 | -7.4% | 2,500,000 | 0.0% | 1.42% | -10.4% |
| Q4 2015 | $1,775,000 | -34.2% | 2,500,000 | -37.5% | 1.58% | -40.9% |
| Q3 2015 | $2,698,000 | -15.6% | 4,000,000 | 0.0% | 2.68% | -1.0% |
| Q2 2015 | $3,196,000 | +4.4% | 4,000,000 | 0.0% | 2.70% | +15.1% |
| Q1 2015 | $3,060,000 | -4.4% | 4,000,000 | 0.0% | 2.35% | -7.2% |
| Q4 2014 | $3,200,000 | – | 4,000,000 | – | 2.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|